12:00 AM
 | 
Sep 15, 2004
 |  BC Extra  |  Company News

Neurogen, Sanofi-Aventis ending CRF1 deal

NRGN and Sanofi- Aventis S.A. (Euronext:SAN; SNY) will terminate on Dec. 8 their 2001 deal to...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >